Dimensional Fund Advisors’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-269,731
| Closed | -$5.83K | – | 3535 |
|
|
2022
Q4 | $5.83K | Buy |
269,731
+5,195
| +2% | +$110K | ﹤0.01% | 2399 |
|
|
2022
Q3 | $5.12M | Sell |
264,536
-124,321
| -32% | -$2.57M | ﹤0.01% | 2417 |
|
|
2022
Q2 | $7.72M | Buy |
388,857
+27,796
| +8% | +$733K | ﹤0.01% | 2308 |
|
|
2022
Q1 | $10.8M | Buy |
361,061
+34,486
| +11% | +$1.01M | ﹤0.01% | 2264 |
|
|
2021
Q4 | $7.61M | Buy |
326,575
+13,107
| +4% | +$348K | ﹤0.01% | 2414 |
|
|
2021
Q3 | $9.78M | Sell |
313,468
-71,626
| -19% | -$2.22M | ﹤0.01% | 2339 |
|
|
2021
Q2 | $13.5M | Buy |
385,094
+32,051
| +9% | +$1.04M | ﹤0.01% | 2224 |
|
|
2021
Q1 | $12.4M | Buy |
353,043
+64,607
| +22% | +$2.39M | ﹤0.01% | 2240 |
|
|
2020
Q4 | $10.8M | Buy |
288,436
+40,716
| +16% | +$1.48M | ﹤0.01% | 2250 |
|
|
2020
Q3 | $8.27M | Buy |
247,720
+3,632
| +1% | +$106K | ﹤0.01% | 2279 |
|
|
2020
Q2 | $6.47M | Buy |
244,088
+9,096
| +4% | +$215K | ﹤0.01% | 2379 |
|
|
2020
Q1 | $3.85M | Buy |
234,992
+16,324
| +7% | +$359K | ﹤0.01% | 2508 |
|
|
2019
Q4 | $5.56M | Buy |
218,668
+2,726
| +1% | +$54.5K | ﹤0.01% | 2577 |
|
|
2019
Q3 | $4.32M | Buy |
215,942
+7,542
| +4% | +$195K | ﹤0.01% | 2644 |
|
|
2019
Q2 | $6.72M | Buy |
208,400
+48,710
| +31% | +$1.63M | ﹤0.01% | 2557 |
|
|
2019
Q1 | $5.14M | Buy |
159,690
+43,467
| +37% | +$1.17M | ﹤0.01% | 2641 |
|
|
2018
Q4 | $2.85M | Buy |
116,223
+33,390
| +40% | +$883K | ﹤0.01% | 2759 |
|
|
2018
Q3 | $2.73M | Buy |
82,833
+69,431
| +518% | +$2.27M | ﹤0.01% | 2850 |
|
|
2018
Q2 | $476K | Buy |
+13,402
| New | +$434K | ﹤0.01% | 3133 |
|
|
2015
Q3 | – | Sell |
-1,846
| Closed | -$57K | – | 3377 |
|
|
2015
Q2 | $57K | Sell |
1,846
-3
| -0.2% | -$101 | ﹤0.01% | 3333 |
|
|
2015
Q1 | $66K | Hold |
1,849
| – | – | ﹤0.01% | 3295 |
|
|
2014
Q4 | $74K | Hold |
1,849
| – | – | ﹤0.01% | 3342 |
|
|
2014
Q3 | $93K | Sell |
1,849
-13
| -0.7% | -$747 | ﹤0.01% | 3344 |
|
|
2014
Q2 | $121K | Hold |
1,862
| – | – | ﹤0.01% | 3356 |
|
|
2014
Q1 | $152K | Hold |
1,862
| – | – | ﹤0.01% | 3339 |
|
|
2013
Q4 | $128K | Hold |
1,862
| – | – | ﹤0.01% | 3332 |
|
|
2013
Q3 | $176K | Sell |
1,862
-39
| -2% | -$5.08K | ﹤0.01% | 3329 |
|
|
2013
Q2 | $238K | Buy |
+1,901
| New | +$198K | ﹤0.01% | 3289 |
|
Other funds holding ALBO
Dimensional Fund Advisors's ALBO Position: Q1 2023 in Review
Dimensional Fund Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 269,731 shares — an estimated $5.83K sold.
Dimensional Fund Advisors first reported a position in ALBO in Q2 2013 and held it in 28 quarters. The position peaked at $13.5M in Q2 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Dimensional Fund Advisors reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Dimensional Fund Advisors sold 269,731 Albireo Pharma Inc shares in Q1 2023, an estimated $5.83K.
- Dimensional Fund Advisors first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 28 quarters.
- Dimensional Fund Advisors's Albireo Pharma Inc position peaked at $13.5M in Q2 2021.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.